< Back to Management Team

Andrew A. Sauter

Chief Financial Officer

“I am proud to be part of something that will change the face of medicine.”

Mr. Sauter was formerly the chief financial officer for Avigen, a publicly traded biopharmaceutical company. In December 2009, Mr. Sauter oversaw the final sale of the company to a strategic buyer through a structured transaction. Previously, he was an auditor at Ernst & Young and a finance manager at Bank of America. Mr. Sauter holds a B.A. in Economics and Accounting from Claremont McKenna College.